CD44 Activation in Mature B-cell Malignancies by a Novel Recurrent IGH Translocation.
Xiao-Tong Hu,Yun-Wen Chen,Anthony C. T. Liang,Wing-Yan Au,Kai-Yau Wong,Thomas S. K. Wan,Michelle L. Y. Wong,Lijun Shen,Ka-Kui Chan,Tianhuan Guo,Kent-Man Chu,Qian Tao,Chor-Sang Chim,Florence Loong,William W. L. Choi,Liwei Lu,Chi-Chiu So,Li Chong Chan,Yok-Lam Kwong,Raymond H. S. Liang,Gopesh Srivastava
DOI: https://doi.org/10.1182/blood-2009-09-238782
IF: 20.3
2010-01-01
Blood
Abstract:Using inverse polymerase chain reaction, we identified CD44, located on chromosome 11p13, as a novel translocation partner of IGH in 9 of 114 cases of gastric, nongastric extranodal, follicular, and nodal diffuse large B-cell lymphoma (DLBCL). Notably, these translocations involving IGHSmu were detected in follicular lymphomas and exclusively in germinal center B cell-ike (GCB)-DLBCLs. CD44 is not expressed in reactive GC B cells. The IGHSmu/CD44 translocations substitute Smu for the CD44 promoter and remove exon 1 of CD44, resulting in the overexpression of Imu-CD44 hybrid mRNA transcripts activated from derivative 11 that encode a new CD44 variant lacking the leader peptide and with a unique C-terminus (CD44DeltaEx1). When overexpressed in vitro in the CD44(-) GCB-DLBCL cell line BJAB, CD44DeltaEx1-green fluorescent protein localized to the cytoplasm and nucleus, whereas CD44s-green fluorescent protein (standard form) localized to the plasma membrane. The ectopic expression of CD44DeltaEx1 in BJAB cells enhanced their proliferation rate and clonogenic ability, indicating a possible pathogenic role of the translocation.